# Methylphenidate for Ptsd and Stroke Veterans

> **NCT04885257** · PHASE1,PHASE2 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 20 (actual)

## Conditions studied

- PTSD
- Stroke

## Interventions

- **DRUG:** Methylphenidate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04885257
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-14
- **Primary completion:** 2025-05-05
- **Final completion:** 2025-05-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04885257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04885257, "Methylphenidate for Ptsd and Stroke Veterans". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04885257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*